Prévisions du marché des modèles de foie humain en Amérique du Nord jusqu’en 2028 – Impact du COVID-19 et analyse régionale par type (organoïdes hépatiques, foie sur puce, modèles 2D, bioimpression 3D et autres), application (découverte de médicaments, éducation et autres) ) et utilisateur final (entreprises pharmaceutiques et biotechnologiques, instituts de recherche et autres)
TIPRE00026113 |
Pages: 98 |
Biotechnology |
Nov 2021
|
Type: Regional |
Status: Published
Le marché des modèles de foie humain en Amérique du Nord devrait passer de 98 522,08 milliers de dollars américains en 2021 à 2 08 998,55 milliers de dollars américains d’ici 2028 ; on estime qu\'elle connaîtra une croissance à un TCAC de 11,3 % entre 2021 et 2028.\\n\\nLes États-Unis, le Canada et le Mexique sont des économies d\'Amérique du Nord. La prévalence croissante des maladies du foie devrait alimenter la croissance du marché des modèles de foie humain en Amérique du Nord. Le foie est le plus grand organe interne du corps et remplit plus de 500 fonctions. La toxicité hépatique est une préoccupation majeure dans l\'évaluation des risques, car le foie est exposé à la plupart des composés xénobiotiques et à leurs métabolites bioactifs, ce qui le rend sensible aux maladies hépatiques d\'origine chimique. Le virus de l’hépatite C (VHC), le virus de l’hépatite B chronique (VHB), la stéatose hépatique non alcoolique (NAFLD) et la maladie hépatique associée à l’alcool (ALD) sont parmi les principales causes de maladie hépatique chronique. L\'hépatite virale continue d\'être la principale cause de décès dus à une insuffisance hépatique et, dans le même temps, la NAFLD est devenue l\'un des contributeurs à la croissance la plus rapide de la morbidité hépatique et de la mortalité associée. Les maladies hépatiques chroniques telles que la NAFLD ou les infections hépatiques chroniques sont associées à un risque élevé de cancer primitif du foie \"\" carcinome hépatocellulaire (CHC). La cirrhose est bien connue et est la principale cause de CHC, avec une incidence d\'environ 0,5 million et un 5 taux de survie de 10 % par an de 10 %. Selon des estimations récentes, l\'incidence de ce cancer a augmenté à un rythme alarmant, faisant du CHC le cinquième cancer le plus fréquent chez l\'homme et le septième cancer le plus fréquent chez la femme. Le CHC contribue probablement à ~ Le CHC représente 5,6 % de tous les cancers humains, augmentant ainsi le fardeau en 2020. Le CHC est connu pour être la deuxième cause de décès liés au cancer dans la région. Les autres types de cancer du foie sont le carcinome cholangiocellulaire (CCC), une maladie maligne du foie. voies biliaires hépatiques et hépatoblastome. L\'hépatoblastome est la tumeur maligne du foie la plus courante chez les enfants. Ainsi, une augmentation de la prévalence des maladies du foie, y compris les maladies chroniques et aiguës et les infections microbiennes, augmente la demande de modèles de foie dans la région de l\'Amérique du Nord. \\n\\nSelon les Centers for Disease Control and Prevention (CDC), les patients atteints d\'une maladie hépatique chronique ou immunodéprimés courent un risque plus élevé de maladie grave due au COVID-19. L’augmentation rapide des cas de COVID-19 signalés aux États-Unis a nécessité des changements généralisés dans les pratiques de soins de santé à travers le pays. Bien que la transplantation d\'organes constitue souvent une urgence médicale, la demande et l\'utilisation croissantes de ressources hospitalières ont affecté négativement la capacité des centres de transplantation à effectuer ces procédures vitales. Les problèmes liés au COVID-19 ont entravé la transplantation hépatique dans la région, posant une menace pour le marché des modèles de foie humain au cours de la période prévue. \\n\\nGrâce aux nouvelles fonctionnalités et technologies, les fournisseurs peuvent attirer de nouveaux clients et étendre leur présence sur les marchés émergents. Ce facteur est susceptible de stimuler le marché des modèles de foie humain en Amérique du Nord. Le marché des modèles de foie humain en Amérique du Nord devrait croître à un bon TCAC au cours de la période de prévision. \\n\\nChiffre d\'affaires et prévisions du marché des modèles de foie humain en Amérique du Nord jusqu\'en 2028 (en milliers de dollars américains) \\n\\nSegmentation du marché des modèles de foie humain en Amérique du Nord \\nMarché des modèles de foie humain en Amérique du Nord par type\\n- Organoïdes du foie\\n- Foie sur- a-chip\\n- Modèles 2D\\n- Bio-impression 3D\\n- Autres\\nMarché des modèles de foie humain en Amérique du Nord par application\\n- Découverte de médicaments\\n- Éducation\\n- Autres\\nMarché des modèles de foie humain en Amérique du Nord par utilisateur final\\ n- Entreprises pharmaceutiques et biotechnologiques\\n- Instituts de recherche \\n- Autres \\nMarché des modèles de foie humain en Amérique du Nord, par pays\\n- États-Unis \\n- Canada \\n- Mexique \\nMarché des modèles de foie humain en Amérique du Nord - Entreprises mentionnées \\n- BioIVT\\n- CELLINK\\n- Emulate, Inc.\\n- InSphero\\n- Kerafast\\n- MIMETAS BV\\n- ORGANOVO HOLDINGS INC.\\n- THERMO FISHER SCIENTIFIC INC.\\n\\n
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Liver Models Market By Type
1.3.2 North America Human Liver Models Market By Application
1.3.3 North America Human Liver Models Market By End User
1.3.4 North America Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Liver Models Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Diseases
5.1.2 Increasing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Expensive Liver Models
5.3 Market Opportunities
5.3.1 Escalating Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Surging Technology Advancements in Organ Printing.
5.5 Impact analysis
6. Human Liver Models Market North America Analysis
6.1 North America Human Liver Models Market Revenue Forecast and Analysis
7. North America Human Liver Models Market Analysis By Type
7.1 Overview
7.2 North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. North America Human Liver Models Market Analysis By Application
8.1 Overview
8.2 North America Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. North America Human Liver Models Market Analysis By End User
9.1 Overview
9.2 North America Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. North America Human Liver Models Market Country Analysis
10.1 North America: Human Liver Models Market
10.1.1 Overview
10.1.2 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 US: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.1.3 US: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.1.4 US: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.2 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 Canada: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.2.3 Canada: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.2.4 Canada: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.3 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 Mexico: Human Liver Models Market, by Type 20192028 (US$ Thousand)
10.1.2.3.3 Mexico: Human Liver Models Market, by Application 20192028 (US$ Thousand)
10.1.2.3.4 Mexico: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on North America Human Liver Models Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MIMETAS BV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 InSphero
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioIVT
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CELLINK
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 inancial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Kerafast
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ORGANOVO HOLDINGS INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. US: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Human Liver Models Market Segmentation
Figure 2. North America Human Liver Models Market Segmentation, By Country
Figure 3. North America Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. North America Human Liver Models Market Revenue Forecast and Analysis
Figure 9. North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. North America Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. North America 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. North America 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. North America Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. North America Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. North America Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. North America Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. North America Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. North America Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. North America Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. North America: Human Liver Models Market, by Key Country Revenue (2021) (US$ Thousand)
Figure 24. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Human Liver Models Market By Type
1.3.2 North America Human Liver Models Market By Application
1.3.3 North America Human Liver Models Market By End User
1.3.4 North America Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Human Liver Models Market Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Liver Diseases
5.1.2 Increasing Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Expensive Liver Models
5.3 Market Opportunities
5.3.1 Escalating Focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Surging Technology Advancements in Organ Printing.
5.5 Impact analysis
6. Human Liver Models Market North America Analysis
6.1 North America Human Liver Models Market Revenue Forecast and Analysis
7. North America Human Liver Models Market Analysis By Type
7.1 Overview
7.2 North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. North America Human Liver Models Market Analysis By Application
8.1 Overview
8.2 North America Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. North America Human Liver Models Market Analysis By End User
9.1 Overview
9.2 North America Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. North America Human Liver Models Market Country Analysis
10.1 North America: Human Liver Models Market
10.1.1 Overview
10.1.2 North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 US: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.1.3 US: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.1.4 US: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.2 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 Canada: Human Liver Models Market, by Type, 20192028 (US$ Thousand)
10.1.2.2.3 Canada: Human Liver Models Market, by Application, 20192028 (US$ Thousand)
10.1.2.2.4 Canada: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
10.1.2.3 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 Mexico: Human Liver Models Market, by Type 20192028 (US$ Thousand)
10.1.2.3.3 Mexico: Human Liver Models Market, by Application 20192028 (US$ Thousand)
10.1.2.3.4 Mexico: Human Liver Models Market, by End User, 20192028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on North America Human Liver Models Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 MIMETAS BV
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 InSphero
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 BioIVT
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CELLINK
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 inancial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Kerafast
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ORGANOVO HOLDINGS INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. US: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Canada Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Mexico Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Organic Developments Done by Companies
Table 12. Inorganic Developments Done by Companies
Table 13. Glossary of Terms
LIST OF FIGURES
Figure 1. North America Human Liver Models Market Segmentation
Figure 2. North America Human Liver Models Market Segmentation, By Country
Figure 3. North America Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America PEST Analysis
Figure 7. North America Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. North America Human Liver Models Market Revenue Forecast and Analysis
Figure 9. North America Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. North America Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. North America Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. North America 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. North America 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. North America Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. North America Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. North America Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. North America Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. North America Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. North America Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. North America Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. North America Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. North America: Human Liver Models Market, by Key Country Revenue (2021) (US$ Thousand)
Figure 24. North America: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. US: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. Canada: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. Mexico: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
1. BioIVT
2. CELLINK
3. Emulate, Inc.
4. InSphero
5. Kerafast
6. MIMETAS BV
7. ORGANOVO HOLDINGS INC.
8. THERMO FISHER SCIENTIFIC INC.
2. CELLINK
3. Emulate, Inc.
4. InSphero
5. Kerafast
6. MIMETAS BV
7. ORGANOVO HOLDINGS INC.
8. THERMO FISHER SCIENTIFIC INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America human liver models market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America human liver models market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Related Reports
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000